There is a raft of new and innovative materials in the constellation of bone augmentation….
curasan AG Receives License for Ceracell® Dental in the USA
curasan AG has received FDA certification for its new granular bone regeneration material Ceracell® Dental
Kleinostheim, Germany, May 07, 2011 –(PR.com)– curasan AG, listed in the General Standard of the German Stock Exchange has received FDA certification for its new granular bone regeneration material Ceracell® Dental.
Ceracell® is a synthetic, completely absorbable and bioactive bone regeneration material. Although the porosity compared to Cerasorb® has been increased considerably yet again, the material has greater mechanical stability. Thanks to the spongy structure designed after human bones and an optimised formulation an increased number of bone-forming cells dock on Ceracell®, which leads to accelerated and qualitatively better bone regeneration.
This is a sampling of the major shift in bone regeneration membranes and graft material towards synthetics, composites and mesenchymal/stem cells.
For interest’s sake, download the articles New Directions 1, 2, 3 from